 |
|
|
|
|
|
|
|
|
|
|
 |
|
|||||||||
 |
 |
 |
 |
 |
 |
 |
 |
|
||
 |
 |
 |
|
|||||||
 |
|
|||||||||
 |
|
|||||||||
Alert Number 72
Date: January 28, 2024
We are delighted that Professor Terry Hamblin accepted our invitation to write this full length article exclusively for readers of CLL Topics. Here is a link to access this must-read article, Are We There Yet? subtitled with another compound question FCR: Is It a Cure?
Dr. Hamblin needs no introduction to CLL patients. In this article he discusses criteria for initiating treatment as well as what treatment can and cannot do for the CLL patient. We heartily second his call for Randomized Controlled Trials (RCTs) to answer many important questions that have been left unanswered by phase II trials. Anecdotal information or skimpy information from statistically under-powered studies with inadequate controls will only slow down the development of real therapeutic options with well understood risk/reward profiles. Dr. Hamblin makes a strong case for randomized controlled trials. We would also add a plea to the researchers: prompt publication and full disclosure of all clinical trial results are very important to us, and are, in our opinion, the only acceptable and ethical standards for clinical trials involving human subjects.
We are grateful to Professor Hamblin for this assessment of where we are in the campaign to cure CLL. Candid assessments such as this are important. How else will we get a fix on where we are, how far we have come, and how much further we need to go?
Be well.
Chaya
_____
NOTICE: This page from the Topics Alert archive was originally emailed to subscribers of Topics Alert, a free service of CLL Topics Inc. If you are not a subscriber and you wish to receive email Alerts, please register at the Topics Alert subscription page. The content of this page is intended for information only and it is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
———
Disclaimer: The content of this website is intended for information only and is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
Copyright Notice:
Copyright © 2024-2007 CLL Topics, Inc. All Rights Reserved.
All materials contained on this site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of CLL Topics, Inc. You may not alter or remove any trademark, copyright or other notice from copies of the content.
However, you may download and print material from CLLTopics.org exclusively for your personal, noncommercial use.
———
